ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,498,382, issued on Dec. 16, was assigned to Incyte Corp. (Wilmington, Del.).
"Biomarkers for vitiligo" was invented by Michael D. Howell (Kennett Square, Pa.), Sherry Owens (Wilmington, Del.), Beth Rumberger (Quarryville, Pa.) and Huiqing Liu (Berwyn, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Biomarkers are provided that are associated with or predictive of a subject's responsiveness to a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing vitiligo."
The patent was filed on Dec. 28, 2022, under Appl...